The Prémio INOVA+ is a national innovation competition promoted by INOVA+ that recognises scientific, business and urban projects with the potential to respond to Europe’s major challenges. Its third edition received 73 applications and distinguished nine projects across three categories.
Prémio INOVA+ · 3rd edition · 2026 3rd place, Business Innovation category, for N1(4)inh-ILNeuroSoV was awarded third place in the Business Innovation category for N1(4)inh-IL, our first-in-class candidate therapy for Parkinson’s disease. The award was received by our CEO Dina Pereira and our CSO Ana Clara Cristóvão at the ceremony held on 4 November at the Lisbon Congress Centre, under the High Patronage of the President of the Republic.
N1(4)inh-IL selectively inhibits NOX1 and NOX4, two enzymes involved in oxidative stress and neuronal degeneration. Its ionic liquid formulation allows intranasal administration, delivering the therapy directly to the brain.
The distinction also includes specialised mentoring on funding programmes, which adds to the support we have been building around the development of our therapy.
